Marshall Wace’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-85,600
| Closed | -$1.06M | – | 3202 |
|
|
2024
Q4 | $1.06M | Sell |
85,600
-407,557
| -83% | -$4.67M | ﹤0.01% | 1706 |
|
|
2024
Q3 | $5.61M | Buy |
493,157
+297,696
| +152% | +$2.99M | 0.01% | 953 |
|
|
2024
Q2 | $1.4M | Buy |
+195,461
| New | +$1.5M | ﹤0.01% | 1537 |
|
|
2024
Q1 | – | Sell |
-247,966
| Closed | -$1.61M | – | 2880 |
|
|
2023
Q4 | $1.61M | Buy |
247,966
+50,975
| +26% | +$329K | ﹤0.01% | 1309 |
|
|
2023
Q3 | $1.86M | Sell |
196,991
-7,583
| -4% | -$91.3K | ﹤0.01% | 1257 |
|
|
2023
Q2 | $2.86M | Sell |
204,574
-68,772
| -25% | -$1.17M | 0.01% | 1242 |
|
|
2023
Q1 | $5.13M | Buy |
+273,346
| New | +$4.49M | 0.01% | 986 |
|
|
2022
Q3 | – | Sell |
-28,505
| Closed | -$435K | – | 3893 |
|
|
2022
Q2 | $435K | Buy |
28,505
+8,023
| +39% | +$119K | ﹤0.01% | 2859 |
|
|
2022
Q1 | $416K | Buy |
+20,482
| New | +$417K | ﹤0.01% | 2855 |
|
|
2021
Q2 | – | Sell |
-16,601
| Closed | -$303K | – | 3192 |
|
|
2021
Q1 | $303K | Sell |
16,601
-6,364
| -28% | -$106K | ﹤0.01% | 2126 |
|
|
2020
Q4 | $265K | Buy |
+22,965
| New | +$210K | ﹤0.01% | 1681 |
|
|
2020
Q3 | – | Sell |
-67,708
| Closed | -$444K | – | 1995 |
|
|
2020
Q2 | $444K | Buy |
+67,708
| New | +$378K | ﹤0.01% | 1228 |
|
|
2019
Q3 | – | Sell |
-324,328
| Closed | -$1.82M | – | 1971 |
|
|
2019
Q2 | $1.82M | Buy |
324,328
+49,383
| +18% | +$204K | 0.01% | 793 |
|
|
2019
Q1 | $1.17M | Buy |
274,945
+154,393
| +128% | +$630K | 0.01% | 886 |
|
|
2018
Q4 | $494K | Buy |
+120,552
| New | +$629K | 0.01% | 1097 |
|
Other funds holding CDMO
Marshall Wace's CDMO Position: Q1 2025 in Review
Marshall Wace sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 85,600 shares — an estimated $1.06M sold.
Marshall Wace first reported a position in CDMO in Q4 2018 and held it in 15 quarters. The position peaked at $5.61M in Q3 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Marshall Wace reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Marshall Wace sold 85,600 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.06M.
- Marshall Wace first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2018 and held it in 15 quarters.
- Marshall Wace's Avid Bioservices, Inc. Common Stock position peaked at $5.61M in Q3 2024.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Marshall Wace's 13F filing for Q1 2025, filed 15 May 2025.